Brown Rudnick has added more depth to its global life sciences bench with the arrival of Neil Di Spirito as a partner in Washington, D.C.

Di Spirito has spent the last three years at Epstein Becker & Green in D.C., and was previously at Ballard Spahr, where he established the firm’s Food and Drug Administration practice. At Brown Rudnick, he will continue his focus on regulatory and compliance services for pharmaceutical, biologics, and medical device clients, especially in FDA interactions and compliance.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]